Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Sarepta Therapeutics (SRPT)

29.75 -0.05 (-0.17%)

3/29/2017  12:55pm

Open:

29.72

Pre. Close:

29.80

High:

30.00

Low:

29.17

Volume:

566,788

Market Cap:

1.63B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

32.01 - 32.68

32.68 - 33.36

Low:

27.84 - 28.44

28.44 - 29.04

Close:

28.83 - 29.86

29.86 - 30.89

Technical analysis  (as of: 2017-03-29 12:49:18 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 37.87     One year: 40.70

Support:

Support1: 28.50    Support2: 23.71

Resistance:

Resistance1: 32.42    Resistance2: 34.85

Pivot:

30.57

Moving Averages:

MA(5): 29.97     MA(20): 31.23

MA(100): 32.35     MA(250): 29.95

MACD:

MACD(12,26): -0.31     Signal(12,26,9): -0.15

%K %D:

%K(14,3): 27.49     %D(3): 26.68

RSI:

RSI(14): 46.34

52-Week:

High: 63.73  Low: 8.00  Change(%): 49.4

Average Vol(K):

3-Month: 2530  10-Days 1309

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SRPT has closed above bottom band by 32.8%. Bollinger Bands are 49.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRPT's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 03 Mar 2017 16:12:01 GMT
2 Reasons Behind Sarepta Therapeutics Inc.'s 6.9% February Jump

Tue, 28 Mar 2017 15:33:45 GMT
Scott+Scott, Attorneys at Law, LLP Announces Investigation of Sarepta ...

Wed, 29 Mar 2017 13:41:15 GMT
Sarepta Therapeutics, Inc. (SRPT) Institutional Ownership stands at 72.6

Fri, 10 Mar 2017 17:26:15 GMT
Sarepta Therapeutics Inc (SRPT): Will Payors Reimburse Exondys 51?

Wed, 29 Mar 2017 15:11:15 GMT
Sarepta Therapeutics, Inc. (SRPT): Ignore the noise and focus on the technicals

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

54.81

Shares Float (M)

45.32

% Held by Insiders

7.79

% Held by Institutions

61.20

Shares Short (K)

9520

Shares Short Prior Month (K)

9120

Stock Financials

EPS

-5.490

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

6.150

PEG Ratio

61.05

Profit Margin

Operating Margin

-4830.75

Return on Assets (ttm)

-46.9

Return on Equity (ttm)

-101.4

Qtrly Rev. Growth

332.6

Gross Profit (p.s.)

0.097

Sales Per Share

0.099

EBITDA (p.s.)

-4.690

Qtrly Earnings Growth

Operating Cash Flow (M)

-245.82

Levered Free Cash Flow (M)

-148.23

FoxReading.com

Valuation

P/E

-5.44

P/E Growth Ratio

P/BV

4.86

P/S

301.96

P/CF

-6.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-07-12

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.